ZIMMER BIOMET HOLDINGS, INC. 4

4 · ZIMMER BIOMET HOLDINGS, INC. · Filed May 16, 2017

Form 4

Period: 2017-05-12

Director

Transactions

Award
Phantom Stock Units
2017-05-12+500→ 7,810.997 total
Exercise: $121.74→ Common Stock (500 underlying)
Award
Restricted Stock Units
2017-05-12+1,067.85→ 15,178.577 total
→ Common Stock (1,067.85 underlying)

Footnotes (6)

[F1]The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.
[F2]The Conversion or Exercise Price of Derivative Security is 1-for-1.
[F3]The units are to be settled in shares of Company company stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units").
[F4]Includes 56.819 phantom stock units accrued between July 29, 2016 and April 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
[F5]The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
[F6]Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Documents

1 file